Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent (TEARIAS): A Multicenter, Open-Label, Single-Blind, Randomized Controlled Trial

NCT07818083 is registered in ClinicalTrials.gov with First Affiliated Hospital of Fujian Medical University as lead sponsor.

NCT NCT07818083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07818083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent (TEARIAS): A Multicenter, Open-Label, Single-Blind, Randomized Controlled Trial
Lead sponsor
First Affiliated Hospital of Fujian Medical University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2028
Enrollment
622 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ruptured intracranial aneurysms, subarachnoid hemorrhage, aneurysmal